Salomon Amar Selected Research

kavain

11/2021	Correction: Kavain Reduces Porphyromonas gingivalis-Induced Adipocyte Inflammation: Role of PGC-1α Signaling.
1/2018	Kavain Reduces Porphyromonas gingivalis-Induced Adipocyte Inflammation: Role of PGC-1α Signaling.
1/2018	Reduction of Articular and Systemic Inflammation by Kava-241 in a Porphyromonas gingivalis-Induced Arthritis Murine Model.
1/2016	Kavain Inhibition of LPS-Induced TNF-α via ERK/LITAF.
11/2011	Receptor activator of nuclear factor kappa B ligand antagonists inhibit tissue inflammation and bone loss in experimental periodontitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Salomon Amar Research Topics

Disease

16	Inflammation (Inflammations) 11/2021 - 08/2002
11	Infections 01/2022 - 02/2002
10	Periodontitis 12/2020 - 08/2002
10	Atherosclerosis 10/2018 - 02/2002
5	Neoplasms (Cancer) 10/2016 - 08/2006
4	Arthritis (Polyarthritis) 10/2019 - 12/2011
4	Periodontal Diseases (Periodontal Disease) 01/2018 - 08/2002
3	Alveolar Bone Loss 01/2018 - 11/2011
3	Bacterial Infections (Bacterial Infection) 01/2017 - 10/2006
3	Bone Resorption 12/2011 - 07/2002
2	Necrosis 09/2013 - 08/2006
2	Shock 12/2011 - 01/2010
2	Atherosclerotic Plaque (Atheroma) 02/2009 - 04/2008
2	Rupture 01/2007 - 10/2006
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Cytokine Release Syndrome 01/2022
1	COVID-19 01/2022
1	Mouth Neoplasms (Oral Cancer) 12/2021
1	Obesity 01/2018
1	Body Weight (Weight, Body) 12/2013
1	B-Cell Lymphoma (Lymphoma, B Cell) 09/2013
1	Communicable Diseases (Infectious Diseases) 01/2013
1	Vascular Remodeling 04/2008
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 07/2006
1	Crohn Disease (Crohn's Disease) 07/2006
1	Ulcerative Colitis 07/2006
1	Endotoxemia 11/2004
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 06/2003

Drug/Important Bio-Agent (IBA)

11	CytokinesIBA 10/2019 - 11/2004
7	CollagenIBA 10/2019 - 12/2011
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2010 - 07/2002
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2005
6	Apolipoproteins E (ApoE)IBA 12/2013 - 02/2002
5	kavainIBA 11/2021 - 11/2011
5	Interleukin-1 (Interleukin 1)IBA 01/2007 - 07/2002
4	LipopolysaccharidesIBA 09/2013 - 07/2002
3	ApolipoproteinsIBA 12/2013 - 02/2002
2	Interleukin-10 (Interleukin 10)IBA 10/2019 - 02/2006
2	Collagen Type II (Type II Collagen)IBA 04/2019 - 11/2017
2	Combined Antibody TherapeuticsIBA 04/2019 - 01/2018
2	LipidsIBA 10/2018 - 04/2008
2	ChemokinesIBA 04/2015 - 11/2004
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2013 - 02/2009
2	DNA (Deoxyribonucleic Acid)IBA 01/2012 - 02/2007
2	Messenger RNA (mRNA)IBA 01/2011 - 07/2006
2	Interleukin-6 (Interleukin 6)IBA 04/2008 - 02/2006
2	Peptide Hydrolases (Proteases)FDA Link 01/2007 - 10/2006
2	InterleukinsIBA 09/2004 - 08/2002
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 09/2004 - 08/2002
1	Pharmaceutical PreparationsIBA 01/2022
1	Carbon DioxideIBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2022
1	Indicators and Reagents (Reagents)IBA 12/2021
1	Virulence Factors (Pathogenicity Factors)IBA 06/2020
1	InterferonsIBA 10/2019
1	Interleukin-12 (IL 12)IBA 10/2019
1	Chemokine CCL5IBA 10/2019
1	Angiotensin IIIBA 10/2018
1	LDL Lipoproteins (beta Lipoproteins)IBA 10/2018
1	Biomarkers (Surrogate Marker)IBA 10/2018
1	KetonesIBA 01/2018
1	BenzamidesIBA 01/2018
1	LactonesIBA 01/2018
1	AdipokinesIBA 01/2018
1	Benzoates (Benzoate)IBA 01/2018
1	Biological ProductsIBA 01/2018
1	AdiponectinIBA 01/2018
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2018
1	MicroRNAs (MicroRNA)IBA 01/2017
1	CholesterolIBA 12/2013
1	NucleotidesIBA 12/2013
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2013
1	16S Ribosomal RNAIBA 01/2012
1	Rank-FcIBA 11/2011
1	RANK LigandIBA 11/2011
1	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 11/2011
1	cyclic 3',5'-thymidine monophosphate (cTMP)IBA 02/2011
1	ChromatinIBA 02/2011
1	Peptides (Polypeptides)IBA 01/2010
1	LigandsIBA 09/2008
1	Saline SolutionIBA 04/2008
1	Doxycycline (Periostat)FDA LinkGeneric 01/2007
1	Transcription Factors (Transcription Factor)IBA 08/2006
1	Interleukin-1beta (Interleukin 1 beta)IBA 02/2006
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 02/2006
1	Nitroglycerin (Dynamite)FDA LinkGeneric 07/2003
1	C-Reactive ProteinIBA 07/2003
1	Advanced Glycation End ProductsIBA 06/2003
1	ProstaglandinsIBA 07/2002
1	Interleukin-11 (Interleukin 11)IBA 07/2002

Therapy/Procedure

1	Therapeutics 01/2022
1	Injections 04/2019
1	Ligation 06/2007
1	Craniotomy 06/2003